Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Ignacio Duran, MD, PhD, of the Hospital Universitario Virgen del Rocío, Seville, Spain, explains the fast pace of research currently in the oncology field; specifically, he mentions combinations of immunotherapy and antiangiogenics for the treatment of kidney cancer. This video was filmed at the 2019 Genitourinary Cancers Symposium, held in San Francisco, CA.
We use necessary cookies to make this site work. Analytics, preference, and marketing cookies are used only if you choose to allow them. You can change your choice at any time. For more information view our Cookie Policy.